| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2801016 | U | LA | 10/22/2024 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
EL9262 |
Neuralgia; Chest pain, Pain in extremity
Neuralgia; Chest pain, Pain in extremity
|
nerve pain; This is a spontaneous report received from a Consumer or other non HCP from medical info...
nerve pain; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID:. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in 2024 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEURALGIA (non-serious) with onset 2024, outcome "not recovered", described as "nerve pain". Additional information: Patient had been having nerve pain since taking the COVID 19 vaccine. Patient was wondering if others have had the same problems, and what, if any, treatment had helped. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
More
|
|||||||
| 2791539 | 63 | F | FL | 09/18/2024 |
COVID19 COVID19 COVID19 COVID19 COVID19 COVID19 TDAP TDAP |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
lm2215 lm2215 LM2215 LM2215 Lm2215 Lm2215 X357E X357E |
Flushing, Hyperhidrosis, Injection site erythema, Pustule, Rash; Pustule, Urtica...
Flushing, Hyperhidrosis, Injection site erythema, Pustule, Rash; Pustule, Urticaria; Flushing, Hyperhidrosis, Injection site erythema, Pustule, Rash; Pustule, Urticaria; Pustule, Rash, Rash pustular, Scar, Skin discolouration; Urticaria; Pustule, Rash, Rash pustular, Scar, Skin discolouration; Urticaria
More
|
Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Flushed /...
Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: patient had postules on her body, Other Vaccines: VaccineTypeBrand: boostrix; Manufacturer: glaxo smithkline; LotNumber: x357e; Route: intramuscular; BodySite: left arm; Dose: ; VaxDate: UNKNOWN
More
|
||||||
| 2819366 | 29 | F | KY | 01/03/2025 |
UNK UNK UNK UNK FLU3 FLU3 TDAP TDAP |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER SANOFI PASTEUR SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
TFAA2426 TFAA2426 3RE73 3RE73 |
Chills, Exposure during pregnancy, Headache, Pain, Pyrexia; Diarrhoea, Headache,...
Chills, Exposure during pregnancy, Headache, Pain, Pyrexia; Diarrhoea, Headache, Pyrexia, Vision blurred, Vomiting; Chills, Exposure during pregnancy, Headache, Pain, Pyrexia; Diarrhoea, Headache, Pyrexia, Vision blurred, Vomiting; Chills, Exposure during pregnancy, Headache, Pain, Pyrexia; Diarrhoea, Headache, Pyrexia, Vision blurred, Vomiting; Chills, Exposure during pregnancy, Headache, Pain, Pyrexia; Diarrhoea, Headache, Pyrexia, Vision blurred, Vomiting
More
|
I am currently 7 months pregnant. My estimate due date is 3-18-2025. My symptoms started about 12 ho...
I am currently 7 months pregnant. My estimate due date is 3-18-2025. My symptoms started about 12 hours after receiving the flu vaccine and a Tdap booster. I?m unsure of the brands. I had a low grade fever, extreme aches and extreme chills, and severe headache. I initially took 1 500 mg Tylenol but the symptoms continued for 12 more hours. I took the next dose of Tylenol (1000 mg) and the symptoms subsided until it was time for the next dose of Tylenol I started getting a fever, chills and aches again. I took more 500 mg Tylenol and the symptoms subsided again after 1 hour.
More
|
||||||
| 2819367 | 66 | M | TN | 01/03/2025 |
PNC20 |
PFIZER\WYETH |
lg5577 |
No adverse event
No adverse event
|
No adverse events noted.
No adverse events noted.
|
||||||
| 2819368 | 0.33 | M | KS | 01/03/2025 |
DTAPHEPBIP DTAPHEPBIP IPV IPV UNK UNK |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR SANOFI PASTEUR UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Behaviour disorder, Blood test, Febrile convulsion, Lethargy, Pyrexia; Speech di...
Behaviour disorder, Blood test, Febrile convulsion, Lethargy, Pyrexia; Speech disorder developmental, Strabismus; Behaviour disorder, Blood test, Febrile convulsion, Lethargy, Pyrexia; Speech disorder developmental, Strabismus; Behaviour disorder, Blood test, Febrile convulsion, Lethargy, Pyrexia; Speech disorder developmental, Strabismus
More
|
Extremely high fever, emergency room visit, lethargic movements on day of given vaccines. Later, ext...
Extremely high fever, emergency room visit, lethargic movements on day of given vaccines. Later, extremely delayed speech, left eye crossed, febrile seizures, ADHD like behavior.
More
|
โ | |||||
| 2818934 | 0.25 | M | 01/02/2025 |
DTAPHEPBIP DTAPHEPBIP DTAPHEPBIP HIBV HIBV HIBV MMR MMR MMR PNC13 PNC13 PNC13 RV1 RV1 RV1 UNK UNK UNK VARCEL VARCEL VARCEL |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. PFIZER\WYETH PFIZER\WYETH PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK UNK |
Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; ...
Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing; Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing; Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing; Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing; Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing; Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing; Chest X-ray normal, Cough, Croup infectious, Dyspnoea, Full blood count normal; Influenza, Influenza A virus test positive, Laryngitis, Nasal congestion, Pyrexia; Respiratory failure, Respiratory syncytial virus test negative, Vomiting, Wheezing
More
|
Influenza A; This 20-month-old male subject was enrolled in a Study to Assess the Safety and Immunog...
Influenza A; This 20-month-old male subject was enrolled in a Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Healthy Infants. The subject received the 4th dose of Bexsero vs Placebo (intramuscular) on 16-JUL-2019, for prophylaxis. The subject received the 4th dose of DTPa-HBV-IPV (intramuscular) on 16-JUL-2019, for prophylaxis. The subject received the 2nd dose of Rotarix lyophilized formulation (intramuscular) on 17-OCT-2018, for prophylaxis. The subject received the 3rd dose of Hiberix (intramuscular) on 21-DEC-2018, for prophylaxis. The subject received the 1st dose of M-M-R II (intramuscular) on 16-JUL-2019, for prophylaxis. The subject received the 1st dose of Varivax (intramuscular) on 16-JUL-2019, for prophylaxis. Co-suspect products included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for prophylaxis. Concomitant products included montelukast sodium (Singulair). On 07-MAR-2020, 235 days after receiving Bexsero vs Placebo, DTPa-HBV-IPV, M-M-R II and Varivax, 507 days after receiving Rotarix lyophilized formulation and 442 days after receiving Hiberix, the subject developed severe - grade 3 influenza a virus infection (Verbatim: Influenza A). Serious criteria included hospitalization. The subject was treated with cetirizine hydrochloride (Zyrtec), amoxicillin, salbutamol (Albuterol), prednisolone, oseltamivir phosphate (Tamiflu) and paracetamol (Tylenol). The outcome of influenza a virus infection was resolved on 20-MAR-2020. Relevant Tests: On 07-MAR-2020 RSV test performed result showed negative. On 11-MAR-2020 RSV test performed result showed negative. On 15-MAR-2020 Chest x-ray showed negative. On 15-MAR-2020 CBC showed negative. On 15-MAR-2020 Flu A showed Positive.. The investigator considered that there was no reasonable possibility that the influenza a virus infection may have been caused by Bexsero vs Placebo, DTPa-HBV-IPV, Rotarix lyophilized formulation, Hiberix, M-M-R II and Varivax. Other possible cause(s) of the influenza a virus infection included DTPa-HBV-IPV vaccine PRE-FILLED SYRINGE DEVICE and Rotavirus vaccine ORAL APPLICATOR DEVICE. The company considered that there was no reasonable possibility that the influenza a virus infection may have been caused by Bexsero vs Placebo, DTPa-HBV-IPV, Rotarix lyophilized formulation, Hiberix, M-M-R II and Varivax. Linked case(s) involving the same subject: US2019200424 GSK Receipt Date: 17-MAR-2020, 24-MAR-2020, 30-MAR-2020, 02-APR-2020, 08-APR-2020, 24-APR-2020, 27-APR-2020, 28-OCT-2020, 12-NOV-2020, 14-DEC-2020, 08-APR-2021, 22-APR-2021, 26-APR-2021, 04-MAY-2021. Subject admitted for Respiratory Failure. Mom stated the subject began having shortness of breath on 15Mar2020 at 9:00 a.m. She treated with Albuterol. subject did not improve so she took him to the hospital. The subject was admitted that night. subject was positive for Flu A. subject was discharged 19Mar2020. Prior to admission, the subject was seen by the Primary care physician on 07Mar2020 and diagnosed with acute obstructive laryngitis (croup) and cough. Also complained of fever, vomiting and difficulty breathing. subject was prescribed Prednisolone and Amoxicillin. subject was seen by Primary care physician on 11Mar2020 for cough, fever, nasal congestion, shortness of breath and wheezing. subject was continuing the Amoxicillin. The PI reviewed the medical record and determined that the SAE term should be Influenza A and not respiratory distress. The respiratory distress was caused by the Influenza A. Follow-up information received on 30-DEC-2024, 31-DEC-2024 Summary of changes: Dose, unit, frequency for medication Singulair, Zyrtec were updated, drug name for Albuterol 0.083 percent was updated and narrative updated.; Sender's Comments: A case of influenza, 235 days after receiving the 4th dose of Bexsero vs Placebo, the 4th dose of DTPa-HBV-IPV, 1st dose of M-M-R II and the 1st dose of Varivax, 442 days after receiving the 3rd dose of Hiberix and 507 days after receiving the 2nd dose of Rotarix lyophilized formulation , in a 20-month-old male subject. Report is inconsistent with causal relation to the vaccine product, considering implausible time to onset, absence of biological plausibility and alternative etiology (On 15-MAR-2020 Flu A showed Positive). US-GLAXOSMITHKLINE-US2019200424:
More
|
โ | ||||||
| 2818938 | 11 | M | PA | 01/02/2025 |
HPV9 HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
|
Eye movement disorder, Immediate post-injection reaction, Injection site rash, M...
Eye movement disorder, Immediate post-injection reaction, Injection site rash, Malaise, Pallor; Palpitations, Posture abnormal, Pyrexia, Rash, Unresponsive to stimuli; Vomiting
More
|
My 11 year old son is NOT allergic to bakers yeast or latex received the gardesil vaccine and within...
My 11 year old son is NOT allergic to bakers yeast or latex received the gardesil vaccine and within seconds his eyes rolled back he slumped in the chair he was unresponsive and started seizing. He developed an immediate rush from his injection site to his wrist, racing heart beat, pale white complexion and high temperature. His doctor pulled his sweatshirt off pant legs up put ice packs on him and gave him benadryl. An hour later he was ok enough to come home but was still not feeling great and threw up a lot.
More
|
||||||
| 2818941 | F | AZ | 01/02/2025 |
FLU3 FLU3 |
SANOFI PASTEUR SANOFI PASTEUR |
|
Bronchitis, Chills, Cough, Eye swelling, Ocular hyperaemia; Oropharyngeal pain, ...
Bronchitis, Chills, Cough, Eye swelling, Ocular hyperaemia; Oropharyngeal pain, Pyrexia
More
|
I received the Fluzone High-Dose Triv 2024-25 on Monday 12/09/2024 thru my Pharmacy. 24 hours later,...
I received the Fluzone High-Dose Triv 2024-25 on Monday 12/09/2024 thru my Pharmacy. 24 hours later, I started to have chills, slight fever, coughing, and a sore throat. By Thurs, the 12th , my eyes were swollen and bloodshot and the coughing had gotten worse. By Monday, the 16th the cough had turned into bronchitis and the eyes were still red. I ended up having to going to my NP to seek treatment for my coughing and red eyes. I was given a Z pak and drops for my eyes all of which took care of the problem. I had gotten flu shots for years and never had this kind of reation to them.
More
|
|||||||
| 2818943 | 51 | F | 01/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Lymphadenopathy, Pain, Vaginal ulceration
Lymphadenopathy, Pain, Vaginal ulceration
|
Had second dose shingles vaccination 12/13/24. On 12/23/24, began developing vaginal sores and swoll...
Had second dose shingles vaccination 12/13/24. On 12/23/24, began developing vaginal sores and swollen lymph nodes in the groin area. Only occurred on left side of body. Sores remain today but are not as painful and seem to be healing.
More
|
|||||||
| 2818944 | 52 | F | 01/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
4H79Y |
Gastrointestinal disorder
Gastrointestinal disorder
|
Gastro intestinal issues after 2nd Shingles Vaccine. Shingrix.
Gastro intestinal issues after 2nd Shingles Vaccine. Shingrix.
|
|||||||
| 2818945 | 48 | M | IL | 01/02/2025 |
UNK UNK |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
PAA165969 PAA165969 |
Arthralgia, Back pain, Blood creatine increased, Dry eye, Fatigue; Hypertension,...
Arthralgia, Back pain, Blood creatine increased, Dry eye, Fatigue; Hypertension, Inflammation, Red blood cell sedimentation rate, Urine analysis
More
|
Fatigue Creatine Protein High Inflammation Sed Rate Inflammation High Blood Messure Joint pain / Ba...
Fatigue Creatine Protein High Inflammation Sed Rate Inflammation High Blood Messure Joint pain / Back Pain Dry Eyes Sar Total Spike
More
|
||||||
| 2818946 | 72 | F | IL | 01/02/2025 |
COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
EM9810 EM9810 EM9810 |
Back pain, Bronchitis chronic, C-reactive protein increased, Dry eye, Fatigue; F...
Back pain, Bronchitis chronic, C-reactive protein increased, Dry eye, Fatigue; Fibrin D dimer increased, Haemoglobin decreased, Hypertension, Inflammation, Red blood cell sedimentation rate abnormal; Urinary tract infection, Urine analysis
More
|
Chronic Bronchitis Fatigue UTI's D- Dimer Elevated Joint Pain ...
Chronic Bronchitis Fatigue UTI's D- Dimer Elevated Joint Pain C Reactive Protein High Dry Eyes Hemoglobin Low Back Pain Inflamation Sed-Rate Inflamation High Blood pressure
More
|
||||||
| 2818993 | 1 | M | DC | 01/02/2025 |
FLU3 MMR PNC20 VARCEL |
SANOFI PASTEUR MERCK & CO. INC. PFIZER\WYETH MERCK & CO. INC. |
|
Product lot number issue; Product lot number issue; Product lot number issue; Pr...
Product lot number issue; Product lot number issue; Product lot number issue; Product lot number issue
More
|
Pt was due for HIB and PCV at time of visit. HIB lot number was documented under PCV20 order. Unable...
Pt was due for HIB and PCV at time of visit. HIB lot number was documented under PCV20 order. Unable to determine if pt received either or both vaccines at visit.
More
|
||||||
| 2818994 | 56 | M | FL | 01/02/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
58160-0823-11 58160-0823-11 |
Burning sensation, Chills, Headache, Injection site erythema, Injection site pai...
Burning sensation, Chills, Headache, Injection site erythema, Injection site pain; Neuralgia, Pain, Pruritus, Pyrexia
More
|
First 24 hours: fever, chills, headache, body ache; injection site pain/redness. Next five days/ongo...
First 24 hours: fever, chills, headache, body ache; injection site pain/redness. Next five days/ongoing: nerve pain/itching/burning over all of body; injection site pain/redness.
More
|
||||||
| 2818995 | 70 | M | FL | 01/02/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
52z52 |
Extra dose administered
Extra dose administered
|
patient received second dose of vaccine
patient received second dose of vaccine
|
||||||
| 2818996 | 4 | F | OH | 01/02/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
U8009AB |
Injection site erythema, Irritability, Pyrexia, Urticaria
Injection site erythema, Irritability, Pyrexia, Urticaria
|
Vaccine given 12/23. Fussy and fever to 101 F within 48 hours. Hives around injection site started...
Vaccine given 12/23. Fussy and fever to 101 F within 48 hours. Hives around injection site started 12/28. Mom giving oral benadryl and topical hydrocortisone cream 1% several times a day but the hives have been recurrent.
More
|
||||||
| 2818997 | 11 | M | 01/02/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
ES49H |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
The resident under the supervison of an attending staff provider ordered the Men B vaccine in error ...
The resident under the supervison of an attending staff provider ordered the Men B vaccine in error and the MA who administered this vaccine is newer and did not catch the error before administration.
More
|
|||||||
| 2818998 | 70 | F | FL | 01/02/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
52z52 |
Extra dose administered
Extra dose administered
|
patient received second dose of rsv
patient received second dose of rsv
|
||||||
| 2818999 | 78 | F | LA | 01/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Urticaria
Urticaria
|
hives
hives
|
||||||
| 2819000 | 0.25 | F | TX | 01/02/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
Vaccine error, given to a 3 month old
Vaccine error, given to a 3 month old
|
||||||
| 2819001 | 4 | M | IN | 01/02/2025 |
DTAPIPV MMRV |
SANOFI PASTEUR MERCK & CO. INC. |
U8209CB Y014438 |
Induration, Necrosis; Induration, Necrosis
Induration, Necrosis; Induration, Necrosis
|
Timeframe within the first 24 hours with severe pain and induration without necrosis. This is consi...
Timeframe within the first 24 hours with severe pain and induration without necrosis. This is consistent with an Arthus reaction. The primary intervention to be made is to defer subsequent Tetanus-Diphtheria vaccinations for 10 years in order to limit likelihood of recurrence.
More
|
||||||
| 2819002 | 25 | F | MS | 01/02/2025 |
COVID19 HPV9 |
PFIZER\BIONTECH MERCK & CO. INC. |
|
Ageusia, Dry eye, Hypoaesthesia oral; Ageusia, Dry eye, Hypoaesthesia oral
Ageusia, Dry eye, Hypoaesthesia oral; Ageusia, Dry eye, Hypoaesthesia oral
|
Dry eyes, no taste, numb lips and tongue. Mouth seems to have a slight droop delay when puckering up...
Dry eyes, no taste, numb lips and tongue. Mouth seems to have a slight droop delay when puckering up. No treatment at the moment but appointment has been scheduled for further testing.
More
|
||||||
| 2819003 | 55 | F | GA | 01/02/2025 |
COVID19 |
MODERNA |
B0001 |
COVID-19, Pain in extremity, SARS-CoV-2 test
COVID-19, Pain in extremity, SARS-CoV-2 test
|
I had no adverse reactions to the injection other than a sore arm for a day or two. However, I beca...
I had no adverse reactions to the injection other than a sore arm for a day or two. However, I became ill with COVID on 12/29/2024 which was within 2 months of vaccination.
More
|
||||||
| 2819004 | 88 | F | FL | 01/02/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
52z52 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient had no reaction, it was a duplicate therapy. Patient received the arexvy vaccine on 12/22/20...
Patient had no reaction, it was a duplicate therapy. Patient received the arexvy vaccine on 12/22/2023 and received another arexvy vaccine on 12/31/2024. Patient's state shot records did not have the vaccine reported on 12/22/2023.
More
|
||||||
| 2819005 | 72 | M | CO | 01/02/2025 |
FLU3 |
SANOFI PASTEUR |
U8519EA |
Extra dose administered, No adverse event, Wrong product administered
Extra dose administered, No adverse event, Wrong product administered
|
Pt given high-dose flu instead of intended covid vaccine. No adverse reaction. Had already been give...
Pt given high-dose flu instead of intended covid vaccine. No adverse reaction. Had already been given annual flu shot on 11/29/24.
More
|
||||||
| 2819006 | 60 | F | CT | 01/02/2025 |
FLU3 FLU3 RSV RSV |
SEQIRUS, INC. SEQIRUS, INC. GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
388532 388532 D7953 D7953 |
Blood test, Dizziness, Headache, Malaise, Rash; Sneezing, Urticaria; Blood test,...
Blood test, Dizziness, Headache, Malaise, Rash; Sneezing, Urticaria; Blood test, Dizziness, Headache, Malaise, Rash; Sneezing, Urticaria
More
|
COULDNT STOP SNEEZING, WELTS AND RASHES, FEELING SICK, DIZZINESS,TERRIBLE HEADACHES, ALL THE TIME
COULDNT STOP SNEEZING, WELTS AND RASHES, FEELING SICK, DIZZINESS,TERRIBLE HEADACHES, ALL THE TIME
|
||||||
| 2819007 | 1.08 | F | WI | 01/02/2025 |
COVID19 |
PFIZER\BIONTECH |
4S5YG |
Product preparation issue
Product preparation issue
|
Patient was given 0.3mLs of the UNDILUTED Covid -19 6m-<5yr vaccine in their left vastus laterali...
Patient was given 0.3mLs of the UNDILUTED Covid -19 6m-<5yr vaccine in their left vastus lateralis.
More
|
||||||
| 2819008 | 64 | M | ID | 01/02/2025 |
VARCEL |
MERCK & CO. INC. |
Merk & Co |
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Patient received Varicella Vaccination 6 days after receiving MMR vaccine.
Patient received Varicella Vaccination 6 days after receiving MMR vaccine.
|
||||||
| 2819009 | 92 | F | KY | 01/02/2025 |
COVID19 |
PFIZER\BIONTECH |
LM2224 |
Death
Death
|
Resident expired
Resident expired
|
โ | |||||
| 2819010 | 26 | F | PA | 01/02/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
K9XL5 |
Arthralgia, Joint range of motion decreased
Arthralgia, Joint range of motion decreased
|
Shoulder pain, decreased range of motion, needing PT treatments
Shoulder pain, decreased range of motion, needing PT treatments
|
||||||
| 2819011 | 84 | F | AL | 01/02/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
52z52 |
Extra dose administered
Extra dose administered
|
Patient received a duplicate Arexvy shot. Last dose was given 12/13/23 at our location but our syst...
Patient received a duplicate Arexvy shot. Last dose was given 12/13/23 at our location but our system did not stop this duplicate fill. I called and spoke with the patient and she was not aware she had the shot back in 2023. She was very understanding.
More
|
||||||
| 2819012 | 94 | F | IA | 01/02/2025 |
COVID19 |
MODERNA |
3043332 |
Death
Death
|
Death
Death
|
โ | |||||
| 2819013 | 43 | M | IL | 01/02/2025 |
UNK UNK |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
COVID 19 COMIRN flu/sh |
Catheterisation cardiac, Chest pain, Dyspnoea, Electrocardiogram abnormal, Myoca...
Catheterisation cardiac, Chest pain, Dyspnoea, Electrocardiogram abnormal, Myocardial infarction; Catheterisation cardiac, Chest pain, Dyspnoea, Electrocardiogram abnormal, Myocardial infarction
More
|
Once I can home from my vaccination on 12/19/24 about an hour later my chest started to hurt. I was ...
Once I can home from my vaccination on 12/19/24 about an hour later my chest started to hurt. I was getting shortage of breath and chest pain.
More
|
โ | โ | ||||
| 2819014 | 76 | M | NH | 01/02/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
|
Agraphia, Amnesia, Aphasia, Balance disorder, Blood test; Dysgraphia, Magnetic r...
Agraphia, Amnesia, Aphasia, Balance disorder, Blood test; Dysgraphia, Magnetic resonance imaging, Reading disorder
More
|
Could no longer spell, read, use computer, difficulty writing, remembering, loss of ability to put t...
Could no longer spell, read, use computer, difficulty writing, remembering, loss of ability to put thoughts into words, balance issues.
More
|
โ | |||||
| 2819016 | 73 | M | MD | 01/02/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
Blood test, Inflammation, Mobility decreased, Pain, X-ray
Blood test, Inflammation, Mobility decreased, Pain, X-ray
|
pt says a couple of days after the flu vaccine he was stepping of a boat onto a dock and he felt a t...
pt says a couple of days after the flu vaccine he was stepping of a boat onto a dock and he felt a twinge in his hip area that went down both sides of his legs but stopped before reaching his knees. It began to progress after the next few days moving up his body towards his torso and both arms, wrist, hands and neck. He was tolerating it dealing with other family matters. He contacted his physician and he was prescribed methopredisone. This medicine helped with the pain from the inflammation he was having from the vaccine. A couple of days after the medicine was out of his system he was back to where he could barely move. His doctor prescribed more steroids. He scheduled an appt with a Rheumotologist Dr. on 11/25/24. He had labs and xrays. He has not received his evaluations from the results on his test until he has a follow up appt. He is not any better at this time.
More
|
||||||
| 2819017 | 0.25 | F | TX | 01/02/2025 |
IPV |
SANOFI PASTEUR |
X1D141M |
Pallor, Vomiting
Pallor, Vomiting
|
No events occured in clinic. Parents called clinic to report that baby had turned pale and vomited ...
No events occured in clinic. Parents called clinic to report that baby had turned pale and vomited x1 approximately 0930 the morning of the vaccine. Infant was at home. No respiratory distress reported. Approximately 1 hour after administration of vaccine. Advised to bring infant in to assess. Infant brought back to clinic at approximately 1040 am on 1/2/25. Exam was WNL, respirations were noted to be even and unlabored at time of exam. Injection site without redness or swelling. VS Stable.
More
|
||||||
| 2819018 | 2 | F | MO | 01/02/2025 |
COVID19 |
PFIZER\BIONTECH |
LN6739 |
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
After administering the vaccine, I realized it had not yet been diluted with saline as we are suppos...
After administering the vaccine, I realized it had not yet been diluted with saline as we are supposed to for the 6mo-4yr vial. The mother of the patient was contacted, the physician was notified, and a hospital report was made. No adverse reaction from the patient at this time.
More
|
||||||
| 2819019 | 1.75 | F | VI | 01/02/2025 |
HIBV |
SANOFI PASTEUR |
UK008AA |
Expired product administered
Expired product administered
|
Gave an expired vaccine. Exp. date 12/31/2024
Gave an expired vaccine. Exp. date 12/31/2024
|
||||||
| 2819020 | 18 | F | MI | 01/02/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
yy37b |
Incorrect dose administered
Incorrect dose administered
|
Patient is under the age 19 and should have been given the pediatric dose vaccine but was given the ...
Patient is under the age 19 and should have been given the pediatric dose vaccine but was given the adult dose
More
|
||||||
| 2819021 | 35 | F | MN | 01/02/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
EL3246 EL9262 |
Cough, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test; Cough,...
Cough, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test; Cough, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test
More
|
Cough x1 month, congestion, sore throat
Cough x1 month, congestion, sore throat
|
||||||
| 2819022 | 12 | F | 01/02/2025 |
MNP |
PFIZER\WYETH |
LJ0077 |
Unevaluable event
Unevaluable event
|
None
None
|
|||||||
| 2819023 | 1.25 | M | MI | 01/02/2025 |
DTAP FLU3 HEPA |
SANOFI PASTEUR SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS |
3CA25C1 U8518BA YA11643 |
Inappropriate schedule of product administration, No adverse event; Inappropriat...
Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event
More
|
Patient was mistakenly given Hepatitis A vaccine before it was due. No adverse affects for patient.
Patient was mistakenly given Hepatitis A vaccine before it was due. No adverse affects for patient.
|
||||||
| 2819024 | 11 | F | 01/02/2025 |
MNP |
PFIZER\WYETH |
LJ0077 |
Unevaluable event
Unevaluable event
|
None
None
|
|||||||
| 2819025 | 76 | F | MA | 01/02/2025 |
RSV RSV |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
49H4G 49H4G |
Catheterisation cardiac normal, Chest X-ray, Dyspnoea, Echocardiogram normal, El...
Catheterisation cardiac normal, Chest X-ray, Dyspnoea, Echocardiogram normal, Electrocardiogram; Exercise tolerance decreased, Feeling abnormal, Myocardial necrosis marker
More
|
Shortness of breath resulting in being unable to exercise ( 2x weekly one mile swimmer) could not co...
Shortness of breath resulting in being unable to exercise ( 2x weekly one mile swimmer) could not complete 5 laps! Also walking any distance, normal housework ?all an extreme effort. Just did not feel ?right? or like myself. Went to urgent care on November 8th, sent to ER. After a whole day of EKG, chest x-ray, bloodwork to check heart enzymes, I was released and told to go to a cardiologist within 72 hours.
More
|
||||||
| 2819026 | 10 | F | IA | 01/02/2025 |
UNK |
UNKNOWN MANUFACTURER |
|
No adverse event
No adverse event
|
There was no adverse event
There was no adverse event
|
||||||
| 2819027 | 12 | M | 01/02/2025 |
MNP |
PFIZER\WYETH |
LJ0077 |
Unevaluable event
Unevaluable event
|
none
none
|
|||||||
| 2819028 | 11 | F | 01/02/2025 |
MNP |
PFIZER\WYETH |
LJ0077 |
Unevaluable event
Unevaluable event
|
None
None
|
|||||||
| 2819029 | 43 | F | NJ | 01/02/2025 |
TDAP |
SANOFI PASTEUR |
|
Erythema, Inflammation, Pain in extremity, Peripheral swelling, Pyrexia
Erythema, Inflammation, Pain in extremity, Peripheral swelling, Pyrexia
|
On the day following the injection, my left hand became red, swollen, and painful, accompanied by a ...
On the day following the injection, my left hand became red, swollen, and painful, accompanied by a fever. By the third day, the entire left hand was painful, with a deep red, circular swelling and a yellowish center, along with persistent fever. I took ibuprofen and Tylenol to manage the pain and inflammation. After consulting my physician, I was advised to monitor the symptoms for two more days, continue the pain medication, and consider antibiotics if necessary.
More
|
||||||
| 2819030 | 1.17 | M | VT | 01/02/2025 |
HEPA HIBV |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR |
5JA57 UK025AA |
No adverse event, Product preparation issue; No adverse event, Product preparati...
No adverse event, Product preparation issue; No adverse event, Product preparation issue
More
|
The child may have only received diluent instead of HIB reconstituted with diluent. There were three...
The child may have only received diluent instead of HIB reconstituted with diluent. There were three patients of which may have been affected. Two received appropriately prepared HIB vaccines and one received diluent. It is unclear which patient of the three received only diluent. No adverse reactions have occurred since the time of administration. The dose is planned to be repeated during the child's 18 month visit to ensure proper vaccination, and the child will be monitored for any reactions at that time. Parents have been notified and expressed understanding of the situation and have no further concerns.
More
|
||||||
| 2819031 | 15 | M | 01/02/2025 |
MNP |
PFIZER\WYETH |
LJ0077 |
Unevaluable event
Unevaluable event
|
none
none
|